Please login to the form below

Not currently logged in
Email:
Password:

Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

He takes up a seat on the company's board of directors

Amylyx Dr Walter GilbertThe founder and former chief executive officer of Biogen Dr Walter Gilbert has been elected to Amylyx Pharmaceuticals' board of directors.

The US-based pharmaceutical firm specialises in developing disease-modifying treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS).

Justin Klee, co-founder and president of Amylyx, said: “Dr Gilbert brings an enormous breadth of experience as a scientist, biotech founder and executive.

“We are honoured that he will join our efforts to advance AMX0035 for the treatment of ALS, which will be tested in an initial clinical trial in patients later this year.”

Over his 40-year career in industry and academia, Dr Gilbert founded several life sciences companies, including Biogen where he was chief executive officer and chairman of the board between 1981 and 1985, and Myriad Genetics where he continues to serve as vice chairman of its board of directors.

Dr Gilbert received the Nobel Prize in Chemistry in 1980 for the development of a rapid method of DNA sequencing, and is currently the Carl M. Loeb University Professor Emeritus at Harvard University.

He said: “Amylyx has assembled an outstanding team that is advancing an innovative approach to ALS and other neurodegenerative diseases.

“I am excited to help bring this promising therapeutic to patients.”

26th January 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics